Sanofi Lands ADEL’s Tau-Targeting Alzheimer’s Contender In $1Bn Deal

Promising Differentiated Mechanism Highlighted

Alzheimer's disease
ADEL/Sanofi Alzheimer's Another Block In Busy 2025 Korean Deal Space (Shutterstock)

More from Deals

More from Business